These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12682634

  • 1. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE.
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [Abstract] [Full Text] [Related]

  • 2. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M, Frankel AE, Alexander RL, Gerhard B, Hogge DE.
    Cancer Res; 2002 Mar 15; 62(6):1730-6. PubMed ID: 11912147
    [Abstract] [Full Text] [Related]

  • 3. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice.
    Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE.
    Bone Marrow Transplant; 1999 Feb 15; 23(3):203-9. PubMed ID: 10084250
    [Abstract] [Full Text] [Related]

  • 4. Human AML cells in NOD/SCID mice: engraftment potential and gene expression.
    Lumkul R, Gorin NC, Malehorn MT, Hoehn GT, Zheng R, Baldwin B, Small D, Gore S, Smith D, Meltzer PS, Civin CI.
    Leukemia; 2002 Sep 15; 16(9):1818-26. PubMed ID: 12200698
    [Abstract] [Full Text] [Related]

  • 5. NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration.
    Nicolini FE, Cashman JD, Hogge DE, Humphries RK, Eaves CJ.
    Leukemia; 2004 Feb 15; 18(2):341-7. PubMed ID: 14628073
    [Abstract] [Full Text] [Related]

  • 6. Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells.
    Feuring-Buske M, Frankel A, Gerhard B, Hogge D.
    Exp Hematol; 2000 Dec 15; 28(12):1390-400. PubMed ID: 11146161
    [Abstract] [Full Text] [Related]

  • 7. Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.
    Ailles LE, Gerhard B, Kawagoe H, Hogge DE.
    Blood; 1999 Sep 01; 94(5):1761-72. PubMed ID: 10477702
    [Abstract] [Full Text] [Related]

  • 8. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ, Shpall EJ, McNiece I, Keller G.
    Biol Blood Marrow Transplant; 1997 Nov 01; 3(5):236-46. PubMed ID: 9450918
    [Abstract] [Full Text] [Related]

  • 9. Good engraftment of B-cell precursor ALL in NOD-SCID mice.
    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.
    Klin Padiatr; 1997 Nov 01; 209(4):178-85. PubMed ID: 9293448
    [Abstract] [Full Text] [Related]

  • 10. The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia.
    Hogge DE, Feuring-Buske M, Gerhard B, Frankel AE.
    Leuk Res; 2004 Nov 01; 28(11):1221-6. PubMed ID: 15380349
    [Abstract] [Full Text] [Related]

  • 11. Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.
    Rombouts WJ, Martens AC, Ploemacher RE.
    Leukemia; 2000 May 01; 14(5):889-97. PubMed ID: 10803522
    [Abstract] [Full Text] [Related]

  • 12. Conditions for engraftment of human acute myeloid leukemia (AML) in SCID mice.
    Terpstra W, Prins A, Visser T, Wognum B, Wagemaker G, Löwenberg B, Wielenga J.
    Leukemia; 1995 Sep 01; 9(9):1573-7. PubMed ID: 7658726
    [Abstract] [Full Text] [Related]

  • 13. Engraftment of acute myeloid leukemia in NOD/SCID mice is independent of CXCR4 and predicts poor patient survival.
    Monaco G, Konopleva M, Munsell M, Leysath C, Wang RY, Jackson CE, Korbling M, Estey E, Belmont J, Andreeff M.
    Stem Cells; 2004 Sep 01; 22(2):188-201. PubMed ID: 14990858
    [Abstract] [Full Text] [Related]

  • 14. Engraftment of NOD/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome.
    Thanopoulou E, Cashman J, Kakagianne T, Eaves A, Zoumbos N, Eaves C.
    Blood; 2004 Jun 01; 103(11):4285-93. PubMed ID: 14962905
    [Abstract] [Full Text] [Related]

  • 15. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease.
    Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E, Lambie K, Shaw G, Holyoake TL, Petzer AL, Auewarakul C, Barnett MJ, Eaves CJ, Eaves AC.
    Leukemia; 2005 Mar 01; 19(3):435-41. PubMed ID: 15674418
    [Abstract] [Full Text] [Related]

  • 16. Retroviral marking of acute myelogenous leukemia progenitors that initiate long-term culture and growth in immunodeficient mice.
    Ailles LE, Humphries RK, Thomas TE, Hogge DE.
    Exp Hematol; 1999 Nov 01; 27(11):1609-20. PubMed ID: 10560908
    [Abstract] [Full Text] [Related]

  • 17. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice.
    Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, Baba E, Tanaka T, Yamasaki S, Gondo H, Otsuka T, Ohshima K, Shultz LD, Akashi K, Harada M.
    Leukemia; 2005 Aug 01; 19(8):1384-90. PubMed ID: 15959532
    [Abstract] [Full Text] [Related]

  • 18. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML).
    Guan Y, Gerhard B, Hogge DE.
    Blood; 2003 Apr 15; 101(8):3142-9. PubMed ID: 12468427
    [Abstract] [Full Text] [Related]

  • 19. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr 15; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 20. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L, Pruneri G, Gobbi A, Rabascio C, Carboni N, Peccatori F, Martinelli G, Bertolini F.
    Cancer Res; 2000 May 01; 60(9):2527-34. PubMed ID: 10811135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.